With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
CGD and CGDE staff continue to work remotely while our DC and London offices remain closed, following guidance from public health officials. Staff are available on email and phone during normal business hours. This page serves as a one-stop repository for all research, analysis, and commentary on COVID-19. Thank you for your continued interest in CGD’s work.
As new cases continue to emerge, what will be the lasting impact of the novel coronavirus?
At CGD, we are examining the toll that the spread of COVID-19 is taking on global development—people, systems, and economies—and how governments and international organizations can best respond. Our experts are also assessing global pandemic preparedness and financing, and in particular how the outbreak will and is affecting low- and middle-income countries—including in Africa—with already-stretched health systems. Drawing upon our work on strengthening health systems and lessons from the 2014-2016 Ebola outbreak in West Africa, we’ve put together options on how global institutions and countries can better respond and prepare for pandemic threats today and in the future. In the race to develop a vaccine, CGD experts are working to leverage the "missing middle"—the private sector and middle-income countries, as well as developed economies. Read about their proposal for a benefits-based advanced market commitment (BBAMC).
To sign up for CGD's coronavirus newsletter, click here.
Contact: Jeremy Gaines
Center for Global Development
+1 (202) 416-4058
With both President Biden and Prime Minister Johnson announcing increased contributions to COVAX, the Center for Global Development’s executive vice president Amanda Glassman, a global health expert and former principal technical lead for health at the Inter-American Development Bank, released the following statement:
“The Biden Administration's move to commit $4 billion to COVAX is a long-overdue step toward ending the pandemic globally, especially since the rise of new variants means that the only way to truly control COVID is to make sure everyone can get vaccinated—not just people in rich countries.”
“Timing is everything. We'd be in a different situation today if COVAX had been fully funded last March. But the world is better off than it was yesterday thanks these big new commitments from the US and UK. Rich countries should do more, because the sooner the funding is available, the sooner we can start dealing with problems like distributing vaccines around the globe.”
“Along with COVAX, wealthy countries need to commit to sharing excess vaccines. Overbuying made sense given how uncertain vaccine development is, but countries like the US, Canada, and the UK are soon going to have more vaccines than people. If we're serious about ending the pandemic, wealthy countries need to make plans now so they’re ready to share surplus vaccines as soon as their own populations are vaccinated.”